Natco settles patent suit with Gilead, others over Tamiflu savita15 Dec 2015 10:43 AM ISTNew Delhi: Natco Pharma and its partner Alvogen said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu, in a...
FDA approves first emergency treatment for chemotherapy overdose savita14 Dec 2015 11:49 AM ISTThe U.S. Food and Drug Administration approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an...
Pfizer receives Prestigious Dr Charles A. Sanders Life Sciences Award Pooja14 Dec 2015 10:25 AM ISTThe CEO Roundtable on Cancer presented the Alliance for Clinical Trials in Oncology and Pfizer with the 2015 Dr. Charles A. Sanders Life Sciences...
US-Based Acorda Therapeutics in Settlement Pact With Aurobindo Pharma Pooja14 Dec 2015 10:20 AM ISTHyderabad: US-based biotechnology company Acorda Therapeutics has said it entered into a settlement agreement with Aurobindo Pharma to...
Roche gets accelerated U.S. approval for lung cancer drug Meghna A Singhania13 Dec 2015 2:55 PM ISTU.S. health regulators on Friday said they have granted accelerated approval to Roche Holding's drug for advanced lung cancer in patients with a...
Sharon receives EIR report from USFDA on inspection closure savita13 Dec 2015 2:52 PM ISTNew Delh: Drug firm Sharon Bio-Medicine said it has received the establishment inspection report (EIR) from the USFDA on closure of inspection of its...
FDA approves Genentech drug for advanced lung cancer savita13 Dec 2015 2:39 PM ISTThe Food and Drug Administration has approved an experimental Genetech drug for patients with a certain type of lung cancer who have few other...
Suven Life Sciences gets patent for neuro-degenerative drug savita12 Dec 2015 1:01 PM ISTNew Delhi: Drug firm Suven Life Sciences has been granted a patent each by Eurasia, Europe, Israel and Macau for a drug used in the treatment of...
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ savita12 Dec 2015 11:14 AM ISTBritish drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion (3.3...
Syngene International to set $100-million manufacturing plant Pooja12 Dec 2015 10:36 AM ISTBiocon's custom research and manufacturing services arm, Syngene International, has announced its plan to launch a manufacturing unit at an investment...
FDA approves new oral therapy to treat ALK-positive lung cancer Pooja12 Dec 2015 9:29 AM ISTThe U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung...
Sun Pharma inks pact to develop nervous system drugs savita12 Dec 2015 9:07 AM ISTNew Delhi: Sun Pharma has entered into an agreement with Israel's Weizmann Institute of Science and Spain's Health Research Institute of Santiago de...
